Simulation for the analysis of distorted pharmacodynamic data

A simulation study was conducted to compare the performance of alternative approaches for analyzing the distorted pharmacodynamic data. The pharmacodynamic data were assumed to be obtained from the natriurertic peptide-type drug, where the diuretic effect arises from the hyperbolic (Emax) dose-respo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical research 1994-04, Vol.11 (4), p.545-548
Hauptverfasser: HASHIMOTO, Y, OZAKI, J, KOUE, T, ODANI, A, YASUHARA, M, HORI, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 548
container_issue 4
container_start_page 545
container_title Pharmaceutical research
container_volume 11
creator HASHIMOTO, Y
OZAKI, J
KOUE, T
ODANI, A
YASUHARA, M
HORI, R
description A simulation study was conducted to compare the performance of alternative approaches for analyzing the distorted pharmacodynamic data. The pharmacodynamic data were assumed to be obtained from the natriurertic peptide-type drug, where the diuretic effect arises from the hyperbolic (Emax) dose-response model and is biased by the dose-dependent hypotensive effect. The nonlinear mixed effect model (NONMEM) method enabled assessment of the effects of hemodynamics on the diuretic effects and also quantification of intrinsic diuretic activities, but the standard two-stage (STS) and naive pooled data (NPD) methods did not give accurate estimates. Both the STS and the NONMEM methods performed well for unbiased data arising from a one-compartment model with saturable (Michaelis-Menten) elimination, whereas the NPD method resulted in inaccurate estimates. The findings suggest that nonlinearity and/or bias problems result in poor estimation by NPD and STS analyses and that the NONMEM method is useful for analyzing such nonlinear and distorted pharmacodynamic data.
doi_str_mv 10.1023/a:1018918600265
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_76652749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76652749</sourcerecordid><originalsourceid>FETCH-LOGICAL-j301t-1bbd91abfd7dcbb3c5a9504018fc9159877644c3a5618e80211299a341b2399d3</originalsourceid><addsrcrecordid>eNo9jztLxEAUhQdR1nW1thJSiF303sxkHoKFLL5gwUIFu3AzM2FnyWPNJMX-ewMGq1N8H4dzGLtEuEXI-B3dI6A2qCVAJvMjtsRc8dSA-D5mS1CZSLUSeMrOYtwBgEYjFmyhIdcS-ZI9fIRmrGkIXZtUXZ8MW59QS_Uhhph0VeJCHLp-8C7Zb6lvyHbu0FITbOJooHN2UlEd_cWcK_b1_PS5fk037y9v68dNuuOAQ4pl6QxSWTnlbFlym5PJQUzDK2swN1opKYTllEvUXkOGmBlDXGCZcWMcX7Gbv9593_2MPg5FE6L1dU2t78ZYKCnzTAkziVezOJaNd8W-Dw31h2L-O_HrmVO0VFc9tTbEf22aJBGA_wIuzWMo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76652749</pqid></control><display><type>article</type><title>Simulation for the analysis of distorted pharmacodynamic data</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>HASHIMOTO, Y ; OZAKI, J ; KOUE, T ; ODANI, A ; YASUHARA, M ; HORI, R</creator><creatorcontrib>HASHIMOTO, Y ; OZAKI, J ; KOUE, T ; ODANI, A ; YASUHARA, M ; HORI, R</creatorcontrib><description>A simulation study was conducted to compare the performance of alternative approaches for analyzing the distorted pharmacodynamic data. The pharmacodynamic data were assumed to be obtained from the natriurertic peptide-type drug, where the diuretic effect arises from the hyperbolic (Emax) dose-response model and is biased by the dose-dependent hypotensive effect. The nonlinear mixed effect model (NONMEM) method enabled assessment of the effects of hemodynamics on the diuretic effects and also quantification of intrinsic diuretic activities, but the standard two-stage (STS) and naive pooled data (NPD) methods did not give accurate estimates. Both the STS and the NONMEM methods performed well for unbiased data arising from a one-compartment model with saturable (Michaelis-Menten) elimination, whereas the NPD method resulted in inaccurate estimates. The findings suggest that nonlinearity and/or bias problems result in poor estimation by NPD and STS analyses and that the NONMEM method is useful for analyzing such nonlinear and distorted pharmacodynamic data.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1023/a:1018918600265</identifier><identifier>PMID: 8058613</identifier><identifier>CODEN: PHREEB</identifier><language>eng</language><publisher>New York, NY: Springer</publisher><subject>Antihypertensive Agents - pharmacokinetics ; Biological and medical sciences ; Diuretics - pharmacokinetics ; Humans ; Injections, Intravenous ; Medical sciences ; Models, Biological ; Models, Statistical ; Pharmacokinetics ; Pharmacology. Drug treatments ; Population ; Urinary system</subject><ispartof>Pharmaceutical research, 1994-04, Vol.11 (4), p.545-548</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4016100$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8058613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HASHIMOTO, Y</creatorcontrib><creatorcontrib>OZAKI, J</creatorcontrib><creatorcontrib>KOUE, T</creatorcontrib><creatorcontrib>ODANI, A</creatorcontrib><creatorcontrib>YASUHARA, M</creatorcontrib><creatorcontrib>HORI, R</creatorcontrib><title>Simulation for the analysis of distorted pharmacodynamic data</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><description>A simulation study was conducted to compare the performance of alternative approaches for analyzing the distorted pharmacodynamic data. The pharmacodynamic data were assumed to be obtained from the natriurertic peptide-type drug, where the diuretic effect arises from the hyperbolic (Emax) dose-response model and is biased by the dose-dependent hypotensive effect. The nonlinear mixed effect model (NONMEM) method enabled assessment of the effects of hemodynamics on the diuretic effects and also quantification of intrinsic diuretic activities, but the standard two-stage (STS) and naive pooled data (NPD) methods did not give accurate estimates. Both the STS and the NONMEM methods performed well for unbiased data arising from a one-compartment model with saturable (Michaelis-Menten) elimination, whereas the NPD method resulted in inaccurate estimates. The findings suggest that nonlinearity and/or bias problems result in poor estimation by NPD and STS analyses and that the NONMEM method is useful for analyzing such nonlinear and distorted pharmacodynamic data.</description><subject>Antihypertensive Agents - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Diuretics - pharmacokinetics</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Medical sciences</subject><subject>Models, Biological</subject><subject>Models, Statistical</subject><subject>Pharmacokinetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Population</subject><subject>Urinary system</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9jztLxEAUhQdR1nW1thJSiF303sxkHoKFLL5gwUIFu3AzM2FnyWPNJMX-ewMGq1N8H4dzGLtEuEXI-B3dI6A2qCVAJvMjtsRc8dSA-D5mS1CZSLUSeMrOYtwBgEYjFmyhIdcS-ZI9fIRmrGkIXZtUXZ8MW59QS_Uhhph0VeJCHLp-8C7Zb6lvyHbu0FITbOJooHN2UlEd_cWcK_b1_PS5fk037y9v68dNuuOAQ4pl6QxSWTnlbFlym5PJQUzDK2swN1opKYTllEvUXkOGmBlDXGCZcWMcX7Gbv9593_2MPg5FE6L1dU2t78ZYKCnzTAkziVezOJaNd8W-Dw31h2L-O_HrmVO0VFc9tTbEf22aJBGA_wIuzWMo</recordid><startdate>19940401</startdate><enddate>19940401</enddate><creator>HASHIMOTO, Y</creator><creator>OZAKI, J</creator><creator>KOUE, T</creator><creator>ODANI, A</creator><creator>YASUHARA, M</creator><creator>HORI, R</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19940401</creationdate><title>Simulation for the analysis of distorted pharmacodynamic data</title><author>HASHIMOTO, Y ; OZAKI, J ; KOUE, T ; ODANI, A ; YASUHARA, M ; HORI, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j301t-1bbd91abfd7dcbb3c5a9504018fc9159877644c3a5618e80211299a341b2399d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Antihypertensive Agents - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Diuretics - pharmacokinetics</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Medical sciences</topic><topic>Models, Biological</topic><topic>Models, Statistical</topic><topic>Pharmacokinetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Population</topic><topic>Urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HASHIMOTO, Y</creatorcontrib><creatorcontrib>OZAKI, J</creatorcontrib><creatorcontrib>KOUE, T</creatorcontrib><creatorcontrib>ODANI, A</creatorcontrib><creatorcontrib>YASUHARA, M</creatorcontrib><creatorcontrib>HORI, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HASHIMOTO, Y</au><au>OZAKI, J</au><au>KOUE, T</au><au>ODANI, A</au><au>YASUHARA, M</au><au>HORI, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Simulation for the analysis of distorted pharmacodynamic data</atitle><jtitle>Pharmaceutical research</jtitle><addtitle>Pharm Res</addtitle><date>1994-04-01</date><risdate>1994</risdate><volume>11</volume><issue>4</issue><spage>545</spage><epage>548</epage><pages>545-548</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><coden>PHREEB</coden><abstract>A simulation study was conducted to compare the performance of alternative approaches for analyzing the distorted pharmacodynamic data. The pharmacodynamic data were assumed to be obtained from the natriurertic peptide-type drug, where the diuretic effect arises from the hyperbolic (Emax) dose-response model and is biased by the dose-dependent hypotensive effect. The nonlinear mixed effect model (NONMEM) method enabled assessment of the effects of hemodynamics on the diuretic effects and also quantification of intrinsic diuretic activities, but the standard two-stage (STS) and naive pooled data (NPD) methods did not give accurate estimates. Both the STS and the NONMEM methods performed well for unbiased data arising from a one-compartment model with saturable (Michaelis-Menten) elimination, whereas the NPD method resulted in inaccurate estimates. The findings suggest that nonlinearity and/or bias problems result in poor estimation by NPD and STS analyses and that the NONMEM method is useful for analyzing such nonlinear and distorted pharmacodynamic data.</abstract><cop>New York, NY</cop><pub>Springer</pub><pmid>8058613</pmid><doi>10.1023/a:1018918600265</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0724-8741
ispartof Pharmaceutical research, 1994-04, Vol.11 (4), p.545-548
issn 0724-8741
1573-904X
language eng
recordid cdi_proquest_miscellaneous_76652749
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Antihypertensive Agents - pharmacokinetics
Biological and medical sciences
Diuretics - pharmacokinetics
Humans
Injections, Intravenous
Medical sciences
Models, Biological
Models, Statistical
Pharmacokinetics
Pharmacology. Drug treatments
Population
Urinary system
title Simulation for the analysis of distorted pharmacodynamic data
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T21%3A58%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Simulation%20for%20the%20analysis%20of%20distorted%20pharmacodynamic%20data&rft.jtitle=Pharmaceutical%20research&rft.au=HASHIMOTO,%20Y&rft.date=1994-04-01&rft.volume=11&rft.issue=4&rft.spage=545&rft.epage=548&rft.pages=545-548&rft.issn=0724-8741&rft.eissn=1573-904X&rft.coden=PHREEB&rft_id=info:doi/10.1023/a:1018918600265&rft_dat=%3Cproquest_pubme%3E76652749%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76652749&rft_id=info:pmid/8058613&rfr_iscdi=true